WADA Publishes 2022 Prohibited List

(Ottawa, Ontario – October 27, 2021) – The World Anti-Doping Agency (WADA) has published the 2022 Prohibited List that will come into effect on January 1. The 2022 Prohibited List and the Summary of Major Modifications and Explanatory Notes are both available to the sport community.

The Canadian Centre for Ethics in Sport (CCES) encourages all athletes and support personnel to familiarize themselves with the Prohibited List and the modifications for the coming year.

Notable changes for 2022:

Glucocorticoids (S9)

All injectable routes of administration of glucocorticoids will be prohibited in-competition. Examples of injectable routes include intravenous, intramuscular, periarticular, intra-articular, peritendinous, intratendinous, epidural, intrathecal, intrabursal, intralesional (e.g., intrakeloid), intradermal, and subcutaneous.

There are no changes to the status of other routes of administration of glucocorticoids.

To avoid inadvertent doping violations, athletes should follow the minimum washout periods for glucocorticoids. Washout periods are expressed from the time of administration to the start of the in-competition period and are based on the maximum manufacturer’s licensed doses for these medications. See page 4 of the Summary of Major Modifications and Explanatory Note.

As with any prohibited medication, athletes who have a legitimate medical need for the use of a prohibited glucocorticoid can apply for a medical exemption.

Beta-2 Agonists – Dosage of Salbutamol (S3)

As stated by WADA, the daily dosing time intervals will be modified to 600 micrograms over eight hours starting from the time any dose is taken (previously 800 micrograms over 12 hours). This is to reduce the risk of any potential adverse analytical finding (AAF) arising after high doses are taken at once. The total permitted daily dose remains at 1,600 micrograms over 24 hours. An athlete whose prescribed dose is greater than these limits should inquire about a medical exemption.

Non-approved Substances (S0)

BPC-157, an experimental peptide sold as a supplement, is included in the 2022 List following a re-evaluation of its status. This is the first time a substance has been included by name as an example in section S0 (Non-approved Substances) of the List.

For more information about any of the aforementioned changes, consult the Summary of Major Modifications and Explanatory Notes.

Resources

We caution athletes to exercise a high degree of care with regards to the use of medications, supplements and sport nutrition products.

The following resources will reflect the new Prohibited List by January 1, 2022, as needed:

The Prohibited List is one of eight International Standards that are mandatory for signatories of the World Anti-Doping Code. It identifies which substances and methods are prohibited in- and out-of-competition and which substances are banned in particular sports. The International Olympic Committee first published it in 1963. Since 2004, WADA has been responsible for the preparation and publication of the List, which it updates every year.

Questions? Contact the CCES
About the CCES

The CCES is an independent, national, not-for-profit organization with a responsibility to administer the Canadian Anti-Doping Program. We recognize that true sport can make a great difference for individuals, communities and our country. The CCES acknowledges funding, in part, from the Government of Canada. We are committed to making sport better by working collaboratively to activate a values-based and principle-driven sport system; protecting the integrity of sport from the negative forces of doping and other unethical threats; and advocating for sport that is fair, safe and open to everyone.

For further information, please contact:

Megan Cumming
Corporate Communications Manager
+1 613-521-3340 x3233
[email protected]

See Also...

The Prohibited List

The Prohibited List was first published in 1968 by the International Olympic Committee. Since 2004, the World...